ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry NetEqFin Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FNERHYPOTHETICAL MODEL
Since ’99
+62%
Expense Ratio
0.35%
placeholder
Holdings
293
cap-weighted
Inception
Sep 2020
placeholder
Full Sharpe
0.19
Ann. Return (LS)
3.8%
Ann. Volatility
20.1%
Max Drawdown
-60.4%
Test Sharpe ’19–26
0.37
Test FF5 α (ann.)
3.5%
vs Fama-French 5
Test FF5 α t-stat
0.62
not significant
Monthly turnover
10%
of the long leg, per rebalance
Cumulative return (LS)
62%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.78
what this fund holds
Long leg ann. return
11.4%
buyable, long-only
Long-short Sharpe
0.19
requires shorting
Bottom bucket ann. return
7.6%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

293 of 293 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
22.12%
2AAPL
APPLE INCTechnology$4.90T
22.10%
3AVGO
BROADCOM INCTechnology$1.76T
7.95%
4LLY
ELI LILLY & COHealthcare$1.11T
5.01%
5V
VISA INCFinancial Services$652.82B
2.94%
6JNJ
JOHNSON & JOHNSONHealthcare$609.12B
2.75%
7MA
MASTERCARD INCFinancial Services$480.32B
2.17%
8ABBV
ABBVIE INCHealthcare$449.63B
2.03%
9AMAT
APPLIED MATERIALS INCTechnology$420.53B
1.90%
10LRCX
LAM RESEARCH CORPTechnology$391.80B
1.77%
11GE
GE AEROSPACEIndustrials$361.93B
1.63%
12MRK
MERCK & CO INCHealthcare$314.90B
1.42%
13GEV
GE VERNOVA INCUtilities$284.26B
1.28%
14KLAC
KLA CORPTechnology$277.91B
1.25%
15TXN
TEXAS INSTRUMENTS INCTechnology$258.48B
1.17%
16AMGN
AMGEN INCHealthcare$197.69B
0.89%
17ADI
ANALOG DEVICES INCTechnology$182.83B
0.82%
18QCOM
QUALCOMM INCTechnology$181.06B
0.82%
19ABT
ABBOTT LABORATORIESHealthcare$175.37B
0.79%
20GILD
GILEAD SCIENCES INCHealthcare$166.72B
0.75%
21PFE
PFIZER INCHealthcare$142.77B
0.64%
22APP
APPLOVIN CORPTechnology$142.62B
0.64%
23SCCO
SOUTHERN COPPER CORPBasic Materials$142.48B
0.64%
24BKNG
BOOKING HOLDINGS INCIndustrials$140.78B
0.63%
25CRM
SALESFORCE INCTechnology$139.86B
0.63%
26BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
0.56%
27VRTX
VERTEX PHARMACEUTICALS INCHealthcare$123.26B
0.56%
28ISRG
INTUITIVE SURGICAL INCHealthcare$122.33B
0.55%
29FTNT
FORTINET INCTechnology$118.40B
0.53%
30LMT
LOCKHEED MARTIN CORPIndustrials$117.30B
0.53%
31NEM
NEWMONT CORPBasic Materials$95.76B
0.43%
32ADBE
ADOBE INCTechnology$94.31B
0.43%
33MCO
MOODYS CORPFinancial Services$89.25B
0.40%
34FCX
FREEPORT-MCMORAN INCBasic Materials$83.92B
0.38%
35MMM
3M COIndustrials$83.37B
0.38%
36HCA
HCA HEALTHCARE INCHealthcare$82.34B
0.37%
37ITW
ILLINOIS TOOL WORKS INCIndustrials$79.42B
0.36%
38EMR
EMERSON ELECTRIC COIndustrials$78.14B
0.35%
39REGN
REGENERON PHARMACEUTICALS INCHealthcare$70.94B
0.32%
40TDG
TRANSDIGM GROUP INCIndustrials$67.93B
0.31%
41AME
AMETEK INCIndustrials$54.32B
0.24%
42CIEN
CIENA CORPTechnology$53.00B
0.24%
43EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
0.22%
44MSCI
MSCI INCFinancial Services$45.77B
0.21%
45IDXX
IDEXX LABORATORIES INCHealthcare$44.76B
0.20%
46CMG
CHIPOTLE MEXICAN GRILL INCConsumer Cyclical$44.18B
0.20%
47BDX
BECTON DICKINSON & COHealthcare$43.58B
0.20%
48VMC
VULCAN MATERIALS COBasic Materials$37.41B
0.17%
49TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTDHealthcare$37.30B
0.17%
50WDAY
WORKDAY INCTechnology$35.76B
0.16%
51ALNY
ALNYLAM PHARMACEUTICALS INCHealthcare$35.71B
0.16%
52ONC
BEONE MEDICINES LTDHealthcare$34.68B
0.16%
53ON
ON SEMICONDUCTOR CORPTechnology$34.24B
0.15%
54MLM
MARTIN MARIETTA MATERIALS INCBasic Materials$33.78B
0.15%
55RPRX
ROYALTY PHARMA PLCHealthcare$33.50B
0.15%
56UI
UBIQUITI INCTechnology$33.04B
0.15%
57ZTS
ZOETIS INCHealthcare$32.10B
0.14%
58BIIB
BIOGEN INCHealthcare$30.41B
0.14%
59DXCM
DEXCOM INCHealthcare$29.58B
0.13%
60FICO
FAIR ISAAC CORPTechnology$29.15B
0.13%
61RMD
RESMED INCHealthcare$28.86B
0.13%
62OTIS
OTIS WORLDWIDE CORPIndustrials$28.18B
0.13%
63WSM
WILLIAMS SONOMA INCConsumer Cyclical$26.89B
0.12%
64MTD
METTLER TOLEDO INTERNATIONAL INCHealthcare$26.47B
0.12%
65VRSK
VERISK ANALYTICS INCIndustrials$26.29B
0.12%
66VRSN
VERISIGN INCTechnology$25.27B
0.11%
67ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.11%
68MRNA
MODERNA INCHealthcare$24.53B
0.11%
69EXPD
EXPEDITORS INTERNATIONAL OF WASHINGTON INCIndustrials$23.91B
0.11%
70TEAM
ATLASSIAN CORPTechnology$23.67B
0.11%
71WWD
WOODWARD INCIndustrials$23.41B
0.11%
72UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.10%
73VTRS
VIATRIS INCHealthcare$20.14B
0.09%
74FTV
FORTIVE CORPTechnology$18.83B
0.08%
75NVR
NVR INCConsumer Cyclical$17.52B
0.08%
76NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.08%
77LSCC
LATTICE SEMICONDUCTOR CORPTechnology$17.16B
0.08%
78BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
0.07%
79JAZZ
JAZZ PHARMACEUTICALS PLCHealthcare$15.53B
0.07%
80MEDP
MEDPACE HOLDINGS INCHealthcare$15.36B
0.07%
81CDE
COEUR MINING INCBasic Materials$14.85B
0.07%
82DECK
DECKERS OUTDOOR CORPConsumer Cyclical$14.79B
0.07%
83LOGI
LOGITECH INTERNATIONAL SATechnology$14.76B
0.07%
84EXEL
EXELIXIS INCHealthcare$14.06B
0.06%
85CSL
CARLISLE COMPANIES INCBasic Materials$13.98B
0.06%
86EVR
EVERCORE INCFinancial Services$13.21B
0.06%
87PINS
PINTEREST INCCommunication Services$13.00B
0.06%
88ELAN
ELANCO ANIMAL HEALTH INCHealthcare$12.90B
0.06%
89MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.06%
90DKNG
DRAFTKINGS INCConsumer Cyclical$12.37B
0.06%
91COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.05%
92SEIC
SEI INVESTMENTS COFinancial Services$11.94B
0.05%
93BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.05%
94PODD
INSULET CORPHealthcare$11.36B
0.05%
95TECH
BIO-TECHNE CORPHealthcare$11.29B
0.05%
96CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.05%
97DPZ
DOMINOS PIZZA INCConsumer Cyclical$10.72B
0.05%
98KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.05%
99DOCU
DOCUSIGN INCTechnology$10.07B
0.05%
100AYI
ACUITY INC (DE)Industrials$9.99B
0.05%
101CYTK
CYTOKINETICS INCHealthcare$9.98B
0.04%
102CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.04%
103MANH
MANHATTAN ASSOCIATES INCTechnology$9.66B
0.04%
104IT
GARTNER INCTechnology$9.39B
0.04%
105HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.04%
106PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.04%
107IONS
IONIS PHARMACEUTICALS INCHealthcare$8.99B
0.04%
108SWKS
SKYWORKS SOLUTIONS INCTechnology$8.93B
0.04%
109ALKS
ALKERMES PLCHealthcare$8.79B
0.04%
110TGTX
TG THERAPEUTICS INCHealthcare$8.40B
0.04%
111RGEN
REPLIGEN CORPHealthcare$8.31B
0.04%
112ETSY
ETSY INCConsumer Cyclical$7.98B
0.04%
113DBX
DROPBOX INCTechnology$7.14B
0.03%
114PAYC
PAYCOM SOFTWARE INCTechnology$7.05B
0.03%
115LNTH
LANTHEUS HOLDINGS INCHealthcare$7.00B
0.03%
116CRUS
CIRRUS LOGIC INCTechnology$6.98B
0.03%
117PPC
PILGRIMS PRIDE CORPConsumer Defensive$6.93B
0.03%
118RIOT
RIOT PLATFORMS INCFinancial Services$6.91B
0.03%
119CHE
CHEMED CORPHealthcare$6.77B
0.03%
120MSA
MSA SAFETY INCIndustrials$6.60B
0.03%
121MORN
MORNINGSTAR INCFinancial Services$6.56B
0.03%
122PTCT
PTC THERAPEUTICS INCHealthcare$6.52B
0.03%
123APPF
APPFOLIO INCTechnology$6.36B
0.03%
124CVLT
COMMVAULT SYSTEMS INCTechnology$6.10B
0.03%
125LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.03%
126TWST
TWIST BIOSCIENCE CORPHealthcare$5.84B
0.03%
127AMRX
AMNEAL PHARMACEUTICALS INCHealthcare$5.69B
0.03%
128DAVE
DAVE INCTechnology$5.60B
0.03%
129PEGA
PEGASYSTEMS INCTechnology$5.39B
0.02%
130MC
MOELIS & COFinancial Services$5.30B
0.02%
131TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.02%
132KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.02%
133FCN
FTI CONSULTING INCIndustrials$4.90B
0.02%
134FELE
FRANKLIN ELECTRIC CO INCIndustrials$4.67B
0.02%
135KNF
KNIFE RIVER CORPBasic Materials$4.64B
0.02%
136FHI
FEDERATED HERMES INCFinancial Services$4.46B
0.02%
137MDU
MDU RESOURCES GROUP INCIndustrials$4.42B
0.02%
138ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.02%
139CNS
COHEN & STEERS INCFinancial Services$4.35B
0.02%
140EXLS
EXLSERVICE HOLDINGS INCTechnology$4.30B
0.02%
141BOX
BOX INCTechnology$4.22B
0.02%
142CALM
CAL-MAINE FOODS INCConsumer Defensive$4.20B
0.02%
143PLNT
PLANET FITNESS INCConsumer Cyclical$4.16B
0.02%
144MKTX
MARKETAXESS HOLDINGS INCFinancial Services$4.04B
0.02%
145DOCS
DOXIMITY INCHealthcare$3.94B
0.02%
146POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.02%
147WING
WINGSTOP INCConsumer Cyclical$3.88B
0.02%
148YETI
YETI HOLDINGS INCConsumer Cyclical$3.87B
0.02%
149CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.02%
150OLED
UNIVERSAL DISPLAY CORPTechnology$3.75B
0.02%
151LOPE
GRAND CANYON EDUCATION INCConsumer Defensive$3.72B
0.02%
152ADPT
ADAPTIVE BIOTECHNOLOGIES CORPHealthcare$3.67B
0.02%
153ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.02%
154OGN
ORGANON & COHealthcare$3.55B
0.02%
155AB
ALLIANCEBERNSTEIN HOLDING LPFinancial Services$3.54B
0.02%
156HAE
HAEMONETICS CORPHealthcare$3.54B
0.02%
157RNG
RINGCENTRAL INCTechnology$3.46B
0.02%
158BSM
BLACK STONE MINERALS LPEnergy$3.25B
0.01%
159IDYA
IDEAYA BIOSCIENCES INCHealthcare$3.16B
0.01%
160CARG
CARGURUS INCConsumer Cyclical$3.16B
0.01%
161EXPO
EXPONENT INCIndustrials$3.05B
0.01%
162AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.01%
163USLM
UNITED STATES LIME & MINERALS INCBasic Materials$3.01B
0.01%
164RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.01%
165BEAM
BEAM THERAPEUTICS INCHealthcare$2.83B
0.01%
166SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.01%
167CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.01%
168APAM
ARTISAN PARTNERS ASSET MANAGEMENT INCFinancial Services$2.73B
0.01%
169GRND
GRINDR INCTechnology$2.71B
0.01%
170TARS
TARSUS PHARMACEUTICALS INCHealthcare$2.58B
0.01%
171PBI
PITNEY BOWES INCIndustrials$2.51B
0.01%
172PGNY
PROGYNY INCHealthcare$2.50B
0.01%
173VCEL
VERICEL CORPHealthcare$2.38B
0.01%
174PBH
PRESTIGE CONSUMER HEALTHCARE INCHealthcare$2.36B
0.01%
175BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.01%
176AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.01%
177INTA
INTAPP INCTechnology$2.24B
0.01%
178NEOG
NEOGEN CORPHealthcare$2.24B
0.01%
179SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.01%
180BKE
BUCKLE INCConsumer Cyclical$2.19B
0.01%
181SPB
SPECTRUM BRANDS HOLDINGS INCConsumer Defensive$2.06B
0.01%
182AUPH
AURINIA PHARMACEUTICALS INCHealthcare$2.05B
0.01%
183CDNA
CAREDX INCHealthcare$2.05B
0.01%
184NUVB
NUVATION BIO INCHealthcare$2.03B
0.01%
185SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.01%
186ADMA
ADMA BIOLOGICS INCHealthcare$2.02B
0.01%
187ABCL
ABCELLERA BIOLOGICS INCHealthcare$1.97B
0.01%
188HRMY
HARMONY BIOSCIENCES HOLDINGS INCHealthcare$1.96B
0.01%
189MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.01%
190SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.01%
191MQ
MARQETA INCTechnology$1.85B
0.01%
192SRPT
SAREPTA THERAPEUTICS INCHealthcare$1.82B
0.01%
193ANIP
ANI PHARMACEUTICALS INCHealthcare$1.80B
0.01%
194IMCR
IMMUNOCORE HOLDINGS PLCHealthcare$1.78B
0.01%
195ZYME
ZYMEWORKS INCHealthcare$1.77B
0.01%
196AESI
ATLAS ENERGY SOLUTIONS INCEnergy$1.76B
0.01%
197HROW
HARROW INCHealthcare$1.74B
0.01%
198ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.01%
199INVA
INNOVIVA INCHealthcare$1.60B
0.01%
200XERS
XERIS BIOPHARMA HOLDINGS INCHealthcare$1.52B
0.01%
201SEPN
SEPTERNA INCHealthcare$1.51B
0.01%
202PRGO
PERRIGO CO PLCHealthcare$1.48B
0.01%
203INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.01%
204YELP
YELP INCCommunication Services$1.44B
0.01%
205BRBR
BELLRING BRANDS INCConsumer Defensive$1.41B
0.01%
206ENR
ENERGIZER HOLDINGS INCIndustrials$1.39B
0.01%
207CXM
SPRINKLR INCTechnology$1.37B
0.01%
208PAHC
PHIBRO ANIMAL HEALTH CORPHealthcare$1.35B
0.01%
209NVAX
NOVAVAX INCHealthcare$1.35B
0.01%
210LZ
LEGALZOOMCOM INCIndustrials$1.33B
0.01%
211HLIT
HARMONIC INCTechnology$1.31B
0.01%
212XNCR
XENCOR INCHealthcare$1.30B
0.01%
213NSSC
NAPCO SECURITY TECHNOLOGIES INCIndustrials$1.29B
0.01%
214ARDX
ARDELYX INCHealthcare$1.28B
0.01%
215INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.01%
216DFIN
DONNELLEY FINANCIAL SOLUTIONS INCFinancial Services$1.25B
0.01%
217IRMD
IRADIMED CORPHealthcare$1.24B
0.01%
218CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.01%
219QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.01%
220COLL
COLLEGIUM PHARMACEUTICAL INCHealthcare$1.17B
0.01%
221ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.01%
222MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.01%
223SDGR
SCHRODINGER INCHealthcare$1.14B
0.01%
224CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.00%
225PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.00%
226JANX
JANUX THERAPEUTICS INCHealthcare$992M
0.00%
227MUX
MCEWEN INCBasic Materials$978M
0.00%
228KURA
KURA ONCOLOGY INCHealthcare$964M
0.00%
229TBPH
THERAVANCE BIOPHARMA INCHealthcare$873M
0.00%
230AMPH
AMPHASTAR PHARMACEUTICALS INCHealthcare$871M
0.00%
231NPK
NATIONAL PRESTO INDUSTRIES INCIndustrials$870M
0.00%
232CYRX
CRYOPORT INCIndustrials$832M
0.00%
233PD
PAGERDUTY INCTechnology$794M
0.00%
234RIGL
RIGEL PHARMACEUTICALS INCHealthcare$750M
0.00%
235IBTA
IBOTTA INCTechnology$734M
0.00%
236CLYM
CLIMB BIO INCHealthcare$727M
0.00%
237SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.00%
238SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.00%
239CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.00%
240TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.00%
241TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.00%
242NRDS
NERDWALLET INCCommunication Services$609M
0.00%
243RGR
STURM RUGER & CO INCIndustrials$604M
0.00%
244MYGN
MYRIAD GENETICS INCHealthcare$584M
0.00%
245YEXT
YEXT INCTechnology$535M
0.00%
246TASK
TASKUS INCTechnology$534M
0.00%
247ARVN
ARVINAS INCHealthcare$517M
0.00%
248DNA
GINKGO BIOWORKS HOLDINGS INCHealthcare$517M
0.00%
249RGNX
REGENXBIO INCHealthcare$511M
0.00%
250XOMA
XOMA ROYALTY CORPHealthcare$504M
0.00%
251NRC
NRC HEALTHHealthcare$491M
0.00%
252SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.00%
253IPI
INTREPID POTASH INCBasic Materials$459M
0.00%
254PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.00%
255TMS
TMS INTERNATIONAL CORPBasic Materials$451M
0.00%
256PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
257NVEC
NVE CORPTechnology$418M
0.00%
258USNA
USANA HEALTH SCIENCES INCConsumer Defensive$403M
0.00%
259EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.00%
260NATH
NATHANS FAMOUS INCConsumer Cyclical$393M
0.00%
261UPB
UPSTREAM BIO INCHealthcare$382M
0.00%
262EOLS
EVOLUS INCHealthcare$377M
0.00%
263ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.00%
264NATR
NATURES SUNSHINE PRODUCTS INCConsumer Defensive$359M
0.00%
265ELMD
ELECTROMED INCHealthcare$349M
0.00%
266VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.00%
267MSB
MESABI TRUSTBasic Materials$320M
0.00%
268LYEL
LYELL IMMUNOPHARMA INCHealthcare$311M
0.00%
269TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.00%
270TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.00%
271HCKT
HACKETT GROUP INCTechnology$261M
0.00%
272RNAC
CARTESIAN THERAPEUTICS INCHealthcare$243M
0.00%
273ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.00%
274UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.00%
275ANIK
ANIKA THERAPEUTICS INCHealthcare$203M
0.00%
276INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.00%
277AOUT
AMERICAN OUTDOOR BRANDS INCIndustrials$174M
0.00%
278ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.00%
279AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.00%
280JYNT
JOINT CORPHealthcare$127M
0.00%
281SAMG
SILVERCREST ASSET MANAGEMENT GROUP INCFinancial Services$118M
0.00%
282FTLF
FITLIFE BRANDS INCConsumer Defensive$104M
0.00%
283CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
284ICCC
IMMUCELL CORPHealthcare$101M
0.00%
285RLYB
RALLYBIO CORPHealthcare$87M
0.00%
286CSBR
CHAMPIONS ONCOLOGY INCHealthcare$85M
0.00%
287LFVN
LIFEVANTAGE CORPConsumer Defensive$78M
0.00%
288BGSF
BGSF INCIndustrials$65M
0.00%
289IMA
IMAGENEBIO INCHealthcare$61M
0.00%
290EURK
EUREKA ACQUISITION CORPIndustrials$60M
0.00%
291CAPN
CAYSON ACQUISITION CORPIndustrials$59M
0.00%
292EXOZ
EXOZYMES INCHealthcare$51M
0.00%
293TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $22.18T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
63.9%
Healthcare
20.8%
Financial Services
6.0%
Industrials
5.1%
Basic Materials
2.0%
Utilities
1.3%
Consumer Cyclical
0.7%
Consumer Defensive
0.1%
Communication Services
0.1%
Energy
0.0%

Portfolio Style

Size × value map of the long-leg book

293 classified
Value
Blend
Growth
Large
Mid
Small
3%11
19%50
77%63
<1%23
<1%37
<1%29
<1%24
<1%22
<1%12

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 87% toward Growth. +1% unclassified (22 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt87% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 293 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
2
Failed
3
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    62.8%
    Margin
    -12.2%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    35.5%
    Margin
    -10.5%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 293 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
0.8 (95% CI 0.6-0.9)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
8.1%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
0.84x
within
parametric
0.90x
within
cornish fisher
0.82x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2006
Before publication (pre-2006)
-0.08
Sharpe · -2.3% p.a.
January 1999December 2006 · 96 mo
Since publication
0.40
Sharpe · 6.3% p.a.
January 2007July 2026 · 235 mo
Change in Sharpe+0.48the return flipped from negative to positive since publication

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
65%
17 of 26 3-year windows made money
Worst window
-1.40
Sharpe, January 2003 – December 2005
January 1999July 2026
Median Sharpe
0.30
Dispersion
0.66
Best window
1.51

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.33.1%27.0%
3 yearsp.a.26.1%3.4%
5 yearsp.a.18.5%17.5%
10 yearsp.a.19.5%6.2%
Since inceptionp.a.10.8%1.8%
Calendar years
YearLong legLong-short
20267 mo11.2%11.2%
202527.2%-6.4%
202437.1%6.3%
202338.5%7.8%
2022-21.3%40.0%
202130.4%55.3%
202027.7%-45.7%
201934.4%8.0%
2018-0.0%14.9%
201725.9%2.9%
20165.8%4.5%
20154.4%10.2%
201419.4%12.2%
201334.7%-7.1%
201212.0%-0.6%
20118.6%7.6%
20109.1%-10.3%
200923.6%-14.6%
2008-24.4%48.0%
200710.0%3.1%
200613.6%-0.5%
20053.3%-13.8%
20043.4%-15.4%
200324.0%-12.4%
2002-22.7%13.7%
2001-3.4%33.6%
2000-9.3%25.9%
199916.0%-50.6%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FNER
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2020-09-09 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$22.18T

Methodology

The Foundry NetEqFin Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a NetEqFin signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.